BRPI1011412A2 - composição para liberação sustentada de droga compreendendo alutinante geopolimérico - Google Patents

composição para liberação sustentada de droga compreendendo alutinante geopolimérico

Info

Publication number
BRPI1011412A2
BRPI1011412A2 BRPI1011412A BRPI1011412A BRPI1011412A2 BR PI1011412 A2 BRPI1011412 A2 BR PI1011412A2 BR PI1011412 A BRPI1011412 A BR PI1011412A BR PI1011412 A BRPI1011412 A BR PI1011412A BR PI1011412 A2 BRPI1011412 A2 BR PI1011412A2
Authority
BR
Brazil
Prior art keywords
alutinant
geopolymeric
sustained release
drug composition
release drug
Prior art date
Application number
BRPI1011412A
Other languages
English (en)
Inventor
Häkan Engqvist
Original Assignee
Orexo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orexo Ab filed Critical Orexo Ab
Publication of BRPI1011412A2 publication Critical patent/BRPI1011412A2/pt
Publication of BRPI1011412A8 publication Critical patent/BRPI1011412A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI1011412A 2009-05-08 2010-05-07 composição para liberação sustentada de droga compreendendo aglutinante geopolimérico BRPI1011412A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0900626 2009-05-08
SE1000117 2010-02-08
PCT/GB2010/000910 WO2010128300A1 (en) 2009-05-08 2010-05-07 Composition for sustained drug delivery comprising geopolymeric binder

Publications (2)

Publication Number Publication Date
BRPI1011412A2 true BRPI1011412A2 (pt) 2016-03-15
BRPI1011412A8 BRPI1011412A8 (pt) 2018-01-02

Family

ID=42638663

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1011412A BRPI1011412A8 (pt) 2009-05-08 2010-05-07 composição para liberação sustentada de droga compreendendo aglutinante geopolimérico

Country Status (15)

Country Link
US (2) US9486527B2 (pt)
EP (1) EP2427177B1 (pt)
JP (1) JP5691051B2 (pt)
KR (1) KR101830080B1 (pt)
CN (1) CN102421419B (pt)
AU (1) AU2010244194B2 (pt)
BR (1) BRPI1011412A8 (pt)
CA (1) CA2761000C (pt)
DK (1) DK2427177T3 (pt)
EA (1) EA027618B1 (pt)
ES (1) ES2673196T3 (pt)
IL (1) IL215826A (pt)
MX (1) MX2011011829A (pt)
PL (1) PL2427177T3 (pt)
WO (1) WO2010128300A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2427177T3 (en) * 2009-05-08 2018-06-18 Emplicure Ab Composition for prolonged drug delivery comprising geopolymer binder
NZ599594A (en) 2009-10-30 2014-06-27 Ix Biopharma Ltd Fast dissolving solid dosage form
UA102627C2 (uk) * 2012-03-20 2013-07-25 Общество С Ограниченной Ответственностью "Наномедтраст" Нанокомпозит оксид церію-алюмосилікатні трубки та спосіб його отримання
BR112014026351B1 (pt) 2012-04-25 2022-09-27 Spi Pharma Inc Composições compreendendo microesferas e formulação farmacêutica contendo tais composições
US9730885B2 (en) 2012-07-12 2017-08-15 Mallinckrodt Llc Extended release, abuse deterrent pharmaceutical compositions
CN105050708A (zh) 2012-11-14 2015-11-11 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
US20140194328A1 (en) 2013-01-07 2014-07-10 Vince Alessi Thermoset ceramic compositions and a method of preparation therefor
RU2743447C2 (ru) 2016-02-29 2021-02-18 Эмпликъюре Аб Устройства для испарения и ингаляции никотина
CN105997915A (zh) * 2016-05-16 2016-10-12 张阳 一种高血压治疗用缓释片剂
CN105769798A (zh) * 2016-05-16 2016-07-20 张阳 一种高血压治疗药物的制备方法
CN105997907A (zh) * 2016-05-16 2016-10-12 胡小丽 高血压治疗药丸
KR102007278B1 (ko) 2017-01-19 2019-08-06 가톨릭대학교 산학협력단 바이러스 진단 및 치료를 위한 인지능 물질 및 이의 제조방법

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0391893B1 (en) 1983-11-14 1993-08-25 The University of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
GB2196252B (en) 1986-09-18 1990-10-17 London Pharmacy Innovation Gastric controlled-release dosage forms
IT1197316B (it) 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
JP2702953B2 (ja) 1988-01-30 1998-01-26 オリンパス光学工業株式会社 薬液含浸セラミックス
IT1216570B (it) 1988-04-08 1990-03-08 Vectorpharma Int Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
JPH01268104A (ja) * 1988-04-20 1989-10-25 Matsushita Electric Works Ltd チョークコイル
JPH0230988A (ja) 1988-07-20 1990-02-01 Toshiba Corp 宇宙軌道上発電プラント
JPH02268104A (ja) 1989-04-07 1990-11-01 Kanebo Ltd 抗菌性組成物
US5443812A (en) 1989-04-24 1995-08-22 Kanebo Ltd. Stabilized synthetic zeolite and a process for the preparation thereof
JPH07188000A (ja) 1993-12-27 1995-07-25 Bridgestone Corp 薬用被覆材
JPH0930988A (ja) 1995-07-21 1997-02-04 Sumitomo Osaka Cement Co Ltd 薬剤徐放性多孔質セラミックス成形体及びその製造方法
GB2307862A (en) 1995-12-05 1997-06-11 David Jehan Patch structures for transdermal therapy
US6777001B1 (en) 1996-11-25 2004-08-17 Kabushiki Kaisya Advance Method of production of ceramics
US5902591A (en) 1997-04-03 1999-05-11 La Prairie Sa Stable topical cosmetic/pharmaceutical emulsion compositions containing ascorbic acid
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6123925A (en) * 1998-07-27 2000-09-26 Healthshield Technologies L.L.C. Antibiotic toothpaste
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US6635281B2 (en) 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
US20030118641A1 (en) 2000-07-27 2003-06-26 Roxane Laboratories, Inc. Abuse-resistant sustained-release opioid formulation
AUPQ573300A0 (en) 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
US7011841B2 (en) 2000-03-24 2006-03-14 Mark B. Lyles High density porous materials
HUP0300444A3 (en) 2000-04-11 2007-09-28 Sankyo Co Stabilized pharmaceutical compositions containing calcium channel blockers
US20020122828A1 (en) 2001-03-02 2002-09-05 Jun Liu Hybrid porous materials for controlled release
AU2002254036A1 (en) 2001-03-05 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Taste masked pharmaceutical compositions
WO2003035135A1 (en) 2001-09-24 2003-05-01 Boston Scientific Limited Optimized dosing for drug coated stents
CA2778208C (en) 2001-09-28 2015-11-10 Tntgamble Inc. Delivery system for biological component
EP1448231A1 (en) 2001-11-19 2004-08-25 Control Delivery Systems, Inc. Topical delivery of codrugs
US8440220B2 (en) 2002-04-23 2013-05-14 Durect Corporation Transdermal analgesic systems with reduced abuse potential
WO2003092785A1 (en) 2002-04-30 2003-11-13 Morteza Shirkhanzadeh Arrays of microneedles comprising porous calcium phosphate coating and bioactive agents
WO2004024224A1 (en) 2002-09-16 2004-03-25 Sung-Yun Kwon Solid micro-perforators and methods of use
SE524334C2 (sv) 2002-09-30 2004-07-27 Cerbio Tech Ab Värmegenererande biokompatibla keramiska material och förfarande för dess framställning
SE525236C2 (sv) 2002-10-31 2005-01-11 Cerbio Tech Ab Förfarande för framställning av strukturerade keramiska beläggningar och belagda anordningar framställda med detta förfarande
SE524494C2 (sv) 2002-12-31 2004-08-17 Doxa Ab Kemiskt bundna biomaterialelement med skräddarsydda egenskaper
AU2003273010A1 (en) 2003-10-15 2005-05-05 Ltt Bio-Pharma Co., Ltd. Composition containing retinoic acid nanoparticles coated with polyvalent metal inorganic salt
KR20060115398A (ko) 2003-10-29 2006-11-08 독사 악티에볼락 개선된 생체 재료의 초기 및 최종 특성을 위한 2단계시스템
US20050181049A1 (en) 2003-11-19 2005-08-18 Dong Liang C. Composition and method for enhancing bioavailability
CA2548915C (en) * 2003-12-31 2012-10-16 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
JP4832082B2 (ja) 2004-02-03 2011-12-07 久光製薬株式会社 経皮薬物投与装置用インタフェース
US7315758B2 (en) 2004-06-03 2008-01-01 Lynntech, Inc. Transdermal delivery of therapeutic agent
KR101352299B1 (ko) 2004-06-28 2014-02-17 벨로시스 파마슈티컬스 에이/에스 액상 제형용 담체로서의 다공성 정제
EP1768651A4 (en) 2004-07-13 2008-09-10 Altairnano Inc CERAMIC STRUCTURES FOR THE PREVENTION OF MEDICINAL USE
WO2006017337A1 (en) * 2004-07-13 2006-02-16 Altairnano, Inc. Ceramic structures for controlled release of drugs
US7537590B2 (en) 2004-07-30 2009-05-26 Microchips, Inc. Multi-reservoir device for transdermal drug delivery and sensing
EP1791520A2 (en) 2004-08-19 2007-06-06 Alza Corporation Controlled release nanoparticle active agent formulation dosage forms and methods
US8535702B2 (en) 2005-02-01 2013-09-17 Boston Scientific Scimed, Inc. Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility
FR2881652B1 (fr) 2005-02-08 2007-05-25 Flamel Technologies Sa Forme pharmaceutique orale microparticulaire anti-mesuage
US20060210634A1 (en) 2005-03-04 2006-09-21 Moerck Rudi E Ceramic structures for controlled release of biologically active substances
DE102005040429A1 (de) 2005-08-25 2007-03-01 Heraeus Kulzer Gmbh Wirkstofffreisetzungssystem und seine Verwendung
US8652529B2 (en) 2005-11-10 2014-02-18 Flamel Technologies Anti-misuse microparticulate oral pharmaceutical form
US7682445B2 (en) 2005-12-08 2010-03-23 Doxa Ab Powdered CBC system with improved reaction feature
US20090104286A1 (en) 2005-12-29 2009-04-23 Robert Basic Regulation of allergic reaction
US20070212414A1 (en) 2006-03-08 2007-09-13 Penwest Pharmaceuticals Co. Ethanol-resistant sustained release formulations
US20070248656A1 (en) * 2006-04-25 2007-10-25 Galer Bradley S Topical preparation dispensers and methods of using the same
US9023400B2 (en) 2006-05-24 2015-05-05 Flamel Technologies Prolonged-release multimicroparticulate oral pharmaceutical form
DE102006028781A1 (de) 2006-06-23 2007-12-27 Robert Bosch Gmbh Verfahren zur Herstellung von porösen Mikronadeln und ihre Verwendung
US20080214987A1 (en) 2006-12-22 2008-09-04 Nanomed Devices, Inc. Microdevice And Method For Transdermal Delivery And Sampling Of Active Substances
WO2008105738A1 (en) 2007-03-01 2008-09-04 Doxa Ab Injectable cement composition for orthopaedic and dental use
US8778377B2 (en) 2007-03-01 2014-07-15 Doxa Ab Drug implant carrier for drug delivery
WO2008105737A1 (en) 2007-03-01 2008-09-04 Doxa Ab Stable cement composition for orthopaedic and dental use
EP2139531A4 (en) * 2007-03-28 2013-01-09 Doxa Ab CARRIER FOR DRUG DISPENSING
CN101104080B (zh) * 2007-04-24 2011-06-22 深圳市鸿华投资有限公司 沸石止血敷料及其制备方法和用途
GB0709541D0 (en) 2007-05-17 2007-06-27 Jagotec Ag Pharmaceutical excipient
EP2100850A1 (en) 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
EP2398577A2 (en) 2009-02-19 2011-12-28 Bonner, Alex Garfield Porous interpenetrating polymer network
DK2427177T3 (en) * 2009-05-08 2018-06-18 Emplicure Ab Composition for prolonged drug delivery comprising geopolymer binder
CA2809927C (en) * 2010-09-07 2019-08-20 Orexo Ab A transdermal drug administration device

Also Published As

Publication number Publication date
ES2673196T3 (es) 2018-06-20
DK2427177T3 (en) 2018-06-18
US9486527B2 (en) 2016-11-08
KR101830080B1 (ko) 2018-02-21
EP2427177A1 (en) 2012-03-14
JP2012526091A (ja) 2012-10-25
US20170112932A1 (en) 2017-04-27
WO2010128300A1 (en) 2010-11-11
BRPI1011412A8 (pt) 2018-01-02
US10092652B2 (en) 2018-10-09
CA2761000A1 (en) 2010-11-11
US20120252845A1 (en) 2012-10-04
PL2427177T3 (pl) 2018-09-28
CA2761000C (en) 2018-05-29
CN102421419A (zh) 2012-04-18
AU2010244194B2 (en) 2014-12-04
AU2010244194A1 (en) 2011-11-10
KR20120015344A (ko) 2012-02-21
MX2011011829A (es) 2012-02-21
IL215826A (en) 2016-11-30
JP5691051B2 (ja) 2015-04-01
EP2427177B1 (en) 2018-03-28
CN102421419B (zh) 2016-05-04
EA027618B1 (ru) 2017-08-31
IL215826A0 (en) 2012-01-31
EA201101596A1 (ru) 2012-05-30

Similar Documents

Publication Publication Date Title
BRPI0919466A2 (pt) composição farmacêutica para liberação modificada
LTPA2018005I1 (lt) Farmacinė kompozicija
BRPI1011412A2 (pt) composição para liberação sustentada de droga compreendendo alutinante geopolimérico
BRPI0909780A2 (pt) Composições e métodos para liberação de fármaco
SMT201700095B (is) Composizioni farmaceutiche per inalazione
ATE518527T1 (de) Rasagilinformulierung mit verzögerter freisetzung
DK3097925T3 (da) Farmaceutisk sammensætning
BRPI0918971A2 (pt) tienopirimidinas para composições farmacêuticas
BRPI1004940A2 (pt) composição farmacêutica
BR112012012108A2 (pt) composição farmacêutica compreendendo propofol
BRPI0914630A2 (pt) liberação dérmica
BRPI0721651A2 (pt) Composição farmacêutica
BRPI0920521A2 (pt) combinação farmacêutica
BRPI1015939A2 (pt) composição farmacêutica
DK2658525T3 (da) Bionedbrydelig lægemiddelafgivelsessammensætning
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
BR112013011967A2 (pt) composição biodegradável para distribuição de fármaco
DK2285413T3 (da) Farmaceutisk sammensætning
DK2120884T3 (da) Farmaceutisk sammensætning
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
BRPI0920287A2 (pt) composição para lavagem de louças
BRPI1006632A2 (pt) composição catalisadora
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
BRPI0921313A2 (pt) composição farmaucêutica
BRPI0912428A2 (pt) formulação farmacêutica sólida de liberação retardada

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11N Dismissal: publication cancelled [chapter 11.14 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25G Requested change of headquarter approved

Owner name: OREXO AB (SE)

B25A Requested transfer of rights approved

Owner name: ADURO MATERIAL AB (SE)

B25A Requested transfer of rights approved

Owner name: EMPLICURE AB (SE)

B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL